Institute of Therapeutic Innovations and Outcomes
The RxOC is uniquely positioned to lead the development of new and effective pharmacy benefit strategies because of its close association with The Ohio State University — a renowned educational and research institution. As a result of the RxOC’s exclusive relationship with the Institute of Therapeutic Innovations and Outcomes (ITIO) housed at the OSU College of Pharmacy, members of the RxOC have access to unique research support unmatched in the state of Ohio.
The quality, accuracy, and relevancy of information that we provide about drug effectiveness and optimum usage have high value because of the unbiased experts in the pharmaceutical field who are part of our team. Having such independence also means that we are not beholden to or influenced by the pharmaceutical industry.
The important relationships throughout the country as a result of our alliance with the ITIO gives the RxOC access to a “think tank” of the nation’s top physicians, pharmacists, and researchers. These experts not only publish their own independent research on pharmaceutical drugs, but are also contracted by the RxOC to conduct studies on the issues our members find most pressing. The result is that members of the RxOC can have complete confidence in the solutions they present to their plan participants.
The RxOC provides access to the ITIO’s findings as a standard part of our members’ benefit programs. Our commitment to offer impartial, independent, evidence-based solutions means that our members will gain ground as new approaches are identified to control the usage and costs of prescription drugs. With the research that comes from ITIO, the RxOC has the tools to help outline the best benefits program for each employer. All members are autonomous in the development of their plans so they are able to choose the best solutions for the demographics they serve. However, members don’t have to make decisions alone. Our staff offers support in several major areas:
- client-specific benefit design, to ensure the most cost-effective prescription plan
- drug evaluation, to provide clinical and economic analyses of drug therapies
- research, to offer findings and opinions on the effectiveness and cost-efficiency of drug therapies
- communication, to ensure that plan participants understand the reason behind any changes to their benefits plan and know how to adapt.